[HTML][HTML] Research Progress on the Relationship between Parkinson's Disease and REM Sleep Behavior Disorder
Y Zhou, X Liu, B Xu - Journal of Integrative Neuroscience, 2024 - imrpress.com
An individual's quality of life is greatly affected by Parkinson's disease (PD), a prevalent
neurological degenerative condition. Rapid eye movement (REM) sleep behavior disorder …
neurological degenerative condition. Rapid eye movement (REM) sleep behavior disorder …
Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson's disease
F Nabizadeh, K Pirahesh, E Ramezannezhad - Neurological Sciences, 2023 - Springer
Background Previous studies investigated CSF levels of α-synuclein (α-syn), amyloid-β (Aβ1-
42), total tau (t-tau), and phosphorylated tau (p-tau) with clinical progression of Parkinson's …
42), total tau (t-tau), and phosphorylated tau (p-tau) with clinical progression of Parkinson's …
Cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in tremor-dominant Parkinson's disease
F Nabizadeh, F Sodeifian, A Kargar - Acta Neurologica Belgica, 2023 - Springer
Background Protein misfolding within specific brain regions is a common characteristic of
neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease (PD) …
neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease (PD) …
IgG index of cerebrospinal fluid can reflect pathophysiology associated with Lewy bodies in Parkinson's disease
H Murakami, T Tokuda, OMA El-Agnaf… - Journal of the …, 2023 - Elsevier
Background Neuroinflammation is one of the pathophysiologies of Parkinson's disease
(PD). Lewy bodies, the pathological hallmark of PD, emerge as a consequence of α …
(PD). Lewy bodies, the pathological hallmark of PD, emerge as a consequence of α …
Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein …
AD Buzoianu, A Sharma, DF Muresanu, L Feng… - … in Nanomedicine in …, 2023 - Springer
Parkinson's disease (PD) in military personnel engaged in combat operations is likely to
develop in their later lives. In order to enhance the quality of lives of PD patients, exploration …
develop in their later lives. In order to enhance the quality of lives of PD patients, exploration …